Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...

Is the universe infinite? It's one of the most profound questions we can ask, and here's the short answer: We don't know. While we have learned a great deal about the universe, a portion of the cosmos ...

GameSpot may get a commission from retail offers. The time of Halo: Infinite is coming to a close. Microsoft and Halo Studios have revealed that the game's next major update, Operation: Infinite, will ...

Microsoft and Halo Studios are looking ahead to the future, but that future will not include new content for Halo Infinite. After four years, the latest installment of the Halo timeline appears poised ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion Pharmaceuticals stock jumped 16% on October 8, 2025, reaching around $6.08 after falling 5.4% the previous day on broader market weakness. The company reported Q2 2025 revenue of $19.2 ...

Abstract: Mathematics is filled with conjectures that involve infinite recursive structure, representing complex structures and underlying deep relationships. Discovering such conjectures is crucial ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...